rs10811661 — CDKN2B

The 9p21 Cell-Cycle Brake on Beta-Cell Growth

Your pancreatic beta cells must periodically replicate to maintain the insulin-producing mass your body needs. At the 9p21 chromosomal locus, a cluster of genes encodes the molecular brakes on cell division — and variants in this region are among the most robustly replicated type 2 diabetes risk factors in the human genome.

rs10811661 sits in a regulatory region immediately upstream of CDKN2A and CDKN2B, genes that encode p16 and p15¹¹ p16 and p15
p16 (CDKN2A) and p15 (CDKN2B) are cyclin-dependent kinase inhibitors — proteins that halt the cell cycle and prevent cell division. In beta cells, they regulate how much renewal can occur over a lifetime.. The same locus also overlaps CDKN2B-AS1 (ANRIL), a long non-coding RNA that regulates the expression of both inhibitors.

The Mechanism

The T risk allele at rs10811661 is associated with altered expression of CDKN2B (p15) and/or ANRIL in pancreatic islets. Upregulation of the CDK inhibitors imposes a stronger proliferative brake on beta cells — reducing the capacity of the pancreas to expand its insulin-producing mass in response to metabolic demand. Unlike many T2D variants that primarily affect insulin secretion per cell, the 9p21 locus is thought to operate at the level of beta-cell mass maintenance²² beta-cell mass maintenance
As beta cells age or are stressed, some die and must be replaced. The 9p21 locus impairs this renewal capacity, so total insulin output declines gradually over decades..

The variant is non-coding and intergenic in nature, acting through regulatory elements that influence local gene expression rather than altering a protein sequence directly. Its effects are additive — each copy of the T allele incrementally reduces beta-cell renewal capacity.

The Evidence

The locus was independently identified in 2007 by three concurrent landmark GWAS: the Diabetes Genetics Initiative³³ Diabetes Genetics Initiative
Saxena et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007. PMID:17463246, the WTCCC study⁴⁴ WTCCC study
Zeggini et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007. PMID:17463249, and the FUSION study⁵⁵ FUSION study
Scott et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007. PMID:17463248.

Subsequent meta-analyses consolidated the signal. A 2012 meta-analysis⁶⁶ 2012 meta-analysis
Cugino et al. Type 2 diabetes and polymorphisms on chromosome 9p21: a meta-analysis. Nutr Metab Cardiovasc Dis 2012. PMID:21315566 pooled 38,455 cases and 60,516 controls across 22 studies, finding a per-allele OR of 1.24 (95% CI 1.21–1.27, P < 10⁻¹⁵) with a clear additive dose-response. Population attributable risk was estimated at 15% in Caucasians and 13% in Asians, meaning roughly one in seven T2D cases in European populations may be attributable to the T allele at this locus.

A broader meta-analysis⁷⁷ broader meta-analysis
Peng et al. The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: a meta-analysis. Gene 2013. PMID:24012816 of 38 studies (51,940 cases, 52,234 controls) found OR 1.17 and noted that age significantly modifies the association (P = 0.003) — the per-allele risk strengthens in older cohorts, consistent with the cumulative beta-cell attrition model.

The T allele is very common (~83% globally), so the TT genotype predominates in most populations. East Asians show notably higher C allele frequencies (~43%) than Africans (~7%), suggesting the C protective allele has undergone positive selection in some populations.

Practical Actions

Because the 9p21 locus affects beta-cell renewal rather than acute insulin secretion, the actionable response is preserving existing beta-cell function and reducing demands on insulin production. Specifically:

• Reducing postprandial glucose spikes lowers the secretory burden on each individual beta cell. Foods with a low glycemic load — legumes, lentils, non-starchy vegetables — reduce the amplitude of glucose excursions after meals.
• Monitoring fasting glucose and HbA1c periodically allows early detection of declining beta-cell reserve before frank diabetes develops.
• Avoiding compounds that are directly cytotoxic to beta cells (excess fructose, saturated fat overload) is specifically relevant to people with limited beta-cell renewal capacity.

Interactions

The 9p21 locus operates independently of the TCF7L2 pathway (rs7903146), which affects Wnt-driven insulin secretion. Carrying risk alleles at both loci compounds diabetes susceptibility through distinct mechanisms — impaired beta-cell mass (9p21) and impaired incretin-stimulated insulin release (TCF7L2). A secondary variant at this same locus, rs564398, shows a weaker independent association (OR ~1.08) and may tag a distinct regulatory element.